Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4011053
[patent_doc_number] => 05879911
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-09
[patent_title] => 'Cell surface protein expressed on human cortical thymocyte and their use'
[patent_app_type] => 1
[patent_app_number] => 8/782682
[patent_app_country] => US
[patent_app_date] => 1997-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 5756
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/879/05879911.pdf
[firstpage_image] =>[orig_patent_app_number] => 782682
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/782682 | Cell surface protein expressed on human cortical thymocyte and their use | Jan 14, 1997 | Issued |
Array
(
[id] => 3834778
[patent_doc_number] => 05846739
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-08
[patent_title] => 'Immunohistochemical detection assay for carcinoma proliferative status'
[patent_app_type] => 1
[patent_app_number] => 8/779870
[patent_app_country] => US
[patent_app_date] => 1997-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2441
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/846/05846739.pdf
[firstpage_image] =>[orig_patent_app_number] => 779870
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/779870 | Immunohistochemical detection assay for carcinoma proliferative status | Jan 5, 1997 | Issued |
Array
(
[id] => 3882093
[patent_doc_number] => 05714148
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-03
[patent_title] => 'Chemical compounds'
[patent_app_type] => 1
[patent_app_number] => 8/722669
[patent_app_country] => US
[patent_app_date] => 1996-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22930
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1039
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/714/05714148.pdf
[firstpage_image] =>[orig_patent_app_number] => 722669
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/722669 | Chemical compounds | Sep 29, 1996 | Issued |
Array
(
[id] => 3881682
[patent_doc_number] => 05723125
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide'
[patent_app_type] => 1
[patent_app_number] => 8/719331
[patent_app_country] => US
[patent_app_date] => 1996-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4618
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723125.pdf
[firstpage_image] =>[orig_patent_app_number] => 719331
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/719331 | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide | Sep 24, 1996 | Issued |
Array
(
[id] => 3874650
[patent_doc_number] => 05747332
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'Methods for purifying and synthesizing heat shock protein complexes'
[patent_app_type] => 1
[patent_app_number] => 8/717239
[patent_app_country] => US
[patent_app_date] => 1996-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2305
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747332.pdf
[firstpage_image] =>[orig_patent_app_number] => 717239
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/717239 | Methods for purifying and synthesizing heat shock protein complexes | Sep 19, 1996 | Issued |
Array
(
[id] => 3851651
[patent_doc_number] => 05705154
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-06
[patent_title] => 'Humanized monoclonal antibodies against human interleukin-4'
[patent_app_type] => 1
[patent_app_number] => 8/704744
[patent_app_country] => US
[patent_app_date] => 1996-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20233
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/705/05705154.pdf
[firstpage_image] =>[orig_patent_app_number] => 704744
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/704744 | Humanized monoclonal antibodies against human interleukin-4 | Sep 5, 1996 | Issued |
Array
(
[id] => 3725140
[patent_doc_number] => 05651969
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-29
[patent_title] => 'Antibody to the neural cell adhesion molecule and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/642374
[patent_app_country] => US
[patent_app_date] => 1996-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4146
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/651/05651969.pdf
[firstpage_image] =>[orig_patent_app_number] => 642374
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/642374 | Antibody to the neural cell adhesion molecule and methods of use | May 2, 1996 | Issued |
Array
(
[id] => 3662438
[patent_doc_number] => 05667978
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-16
[patent_title] => 'Antibody to the neural cell adhesion molecule and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/642288
[patent_app_country] => US
[patent_app_date] => 1996-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4153
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/667/05667978.pdf
[firstpage_image] =>[orig_patent_app_number] => 642288
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/642288 | Antibody to the neural cell adhesion molecule and methods of use | May 2, 1996 | Issued |
08/609218 | METHOD FOR REDUCING THE IMMUNOGENICITY OF ANTIBODY VARIABLE DOMAINS | Feb 29, 1996 | Abandoned |
Array
(
[id] => 3743715
[patent_doc_number] => 05801145
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-01
[patent_title] => 'Method for selectively purging CD77+ cells from bone marrow'
[patent_app_type] => 1
[patent_app_number] => 8/599211
[patent_app_country] => US
[patent_app_date] => 1996-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4457
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/801/05801145.pdf
[firstpage_image] =>[orig_patent_app_number] => 599211
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/599211 | Method for selectively purging CD77+ cells from bone marrow | Feb 8, 1996 | Issued |
08/579211 | NOVEL HYBRID MOLECULE WITH A CYTOKINE AND AN IMMUNOGLOBULIN FC LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE | Dec 27, 1995 | Abandoned |
Array
(
[id] => 3656757
[patent_doc_number] => 05627034
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-06
[patent_title] => 'Assay for carcinoma proliferative status by measuring NGAL expression level'
[patent_app_type] => 1
[patent_app_number] => 8/567509
[patent_app_country] => US
[patent_app_date] => 1995-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4371
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/627/05627034.pdf
[firstpage_image] =>[orig_patent_app_number] => 567509
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/567509 | Assay for carcinoma proliferative status by measuring NGAL expression level | Dec 4, 1995 | Issued |
Array
(
[id] => 3831017
[patent_doc_number] => 05712120
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-27
[patent_title] => 'Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them'
[patent_app_type] => 1
[patent_app_number] => 8/497312
[patent_app_country] => US
[patent_app_date] => 1995-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8032
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/712/05712120.pdf
[firstpage_image] =>[orig_patent_app_number] => 497312
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/497312 | Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them | Jun 29, 1995 | Issued |
08/485786 | METHOD OF PROMOTING AN IMMUNE RESPONSE WITH A BISPECIFIC ANTIBODY | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3810935
[patent_doc_number] => 05770196
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-23
[patent_title] => 'Modified antibody variable domains and therapeutic uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/472788
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 26
[patent_no_of_words] => 27796
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/770/05770196.pdf
[firstpage_image] =>[orig_patent_app_number] => 472788
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472788 | Modified antibody variable domains and therapeutic uses thereof | Jun 6, 1995 | Issued |
Array
(
[id] => 3781580
[patent_doc_number] => 05821123
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'Modified antibody variable domains'
[patent_app_type] => 1
[patent_app_number] => 8/477531
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 26
[patent_no_of_words] => 21757
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821123.pdf
[firstpage_image] =>[orig_patent_app_number] => 477531
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477531 | Modified antibody variable domains | Jun 6, 1995 | Issued |
08/482112 | HUMANIZED ANTIBODIES TO E-SELECTIN | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3775631
[patent_doc_number] => 05808033
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Family of anti-carcinoembryonic antigen chimeric antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/471426
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12359
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/808/05808033.pdf
[firstpage_image] =>[orig_patent_app_number] => 471426
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471426 | Family of anti-carcinoembryonic antigen chimeric antibodies | Jun 5, 1995 | Issued |
Array
(
[id] => 3783315
[patent_doc_number] => 05821238
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'Recombinant pseudomonas exotoxin with increased activity'
[patent_app_type] => 1
[patent_app_number] => 8/461234
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 12167
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821238.pdf
[firstpage_image] =>[orig_patent_app_number] => 461234
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461234 | Recombinant pseudomonas exotoxin with increased activity | Jun 4, 1995 | Issued |
Array
(
[id] => 3696612
[patent_doc_number] => 05645817
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-08
[patent_title] => 'Granulocyte-binding antibody constructs, their preparation and use'
[patent_app_type] => 1
[patent_app_number] => 8/459310
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4005
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/645/05645817.pdf
[firstpage_image] =>[orig_patent_app_number] => 459310
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459310 | Granulocyte-binding antibody constructs, their preparation and use | Jun 1, 1995 | Issued |